Pronađeno: 1-2 / 2 radova

Autori: Clayton David

>> Filter: Samo Article i Review

>> Sve godine

Naslov Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension (Meeting Abstract)
Autori Bar-Or Amit Oh Jiwon Dufek Michal Budincevic Hrvoje Habek Mario Caunt Maresa Thomas Piia Sierzega Malgorzata Clayton David Cheng Ying Fang Ratchford John Goodyear Alexandra Drulovic Jelena S  
Info MULTIPLE SCLEROSIS JOURNAL, (2024), vol. 30 br. 3, Suppl. S, str. 1021-1022
Ispravka Web of Science   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study (Meeting Abstract)
Autori Bar-Or Amit Dufek Michal Budincevic Hrvoje Drulovic Jelena S  Habek Mario Hua Le Weber Martin Thomas Piia Napieralski Julie Clayton David Kuruvilla Denison Qi Qi Xu Yan Goodyear Alexandra Oh Jiwon 
Info MULTIPLE SCLEROSIS JOURNAL, (2023), vol. 29 br. , Suppl. 3, str. 1049-1050
Projekat F. Hoffmann-La Roche Ltd
Ispravka Web of Science   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX